Search For

Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer

Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy

Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma

Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer